Clinical Trial Update: TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension [Phase 3]

View source ↗

Summary

Phase 3 head-to-head trial compared TOBRADEX Ophthalmic Suspension with Tobramycin/dexamethasone ophthalmic suspension in ocular inflammation associated with bl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharoconjunctivitis

Drugs mentioned

• TOBRADEX Ophthalmic Suspension (tobramycin/dexamethasone ophthalmic suspension)
• Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension (tobramycin/dexamethasone ophthalmic suspension)

Snippet

Sponsor: Alcon Research | Conditions: Ocular Inflammation Associated With Blepharaconjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2010-01-14